Putting innovation—and patients—in focus: A conversation with Astellas Pharma CEO Naoki Okamura

📝

内容提要

The Tokyo-based biopharmaceutical company is accelerating its pipeline by innovating at the intersection of biology, modality, and disease.

🏷️

标签

➡️

继续阅读